跳至主要内容
临床试验/ISRCTN19717943
ISRCTN19717943已完成不适用

TARgeted left ventricular lead placement to Guide cardiac rEsynchronisation Therapy in patients with heart failure: a randomised prospective study (TARGET Study)

Papworth Hospital NHS Foundation Trust (UK)0 个研究点目标入组 220 人开始时间: 2011年2月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
220

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Patients (aged 18 years or older, either sex) limited by symptoms of heart failure (New York Heart Association Class III - IV)
  • 2. Left ventricular ejection fraction (LVEF) of less than or equal to 35% and QRS width of greater than or equal to 120 ms despite maximally tolerated doses of standard heart failure treatment (diuretics, angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers, beta blockers and aldosterone antagonists)

排除标准

  • 1. Limiting angina
  • 2. Myocardial infarction within preceding 3 months
  • 3. Significant LV hypertrophy
  • 4. Severe co-morbid illness

研究者

发起方
Papworth Hospital NHS Foundation Trust (UK)

相似试验